Background Patients with atrial fibrillation/flutter (AF) and indication for oral anticoagulants
(OAC) often do not receive them with literature attributing racial, ethnic, gender, and age …

Background Patients with atrial fibrillation/flutter (AF) and indication for oral anticoagulants
(OAC) often do not receive them with literature attributing racial, ethnic, gender, and age …

Introduction Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia,
significantly increasing the risk of stroke. The introduction of direct oral anticoagulants …

Background The competing risk of non-stroke mortality may limit the potential benefit of
stroke prophylaxis therapy in patients with atrial fibrillation and/or atrial flutter (AF). Objective …

Background Appropriate thromboprophylaxis for patients with atrial fibrillation or atrial flutter
(AF) remains a national challenge. The recent availability of direct oral anticoagulants …

Atrial fibrillation (AF) accounts for one-quarter of the global ischemic stroke burden.
Population growth and an increasing prevalence of stroke risk factors underscores the …

Background Direct oral anticoagulants (DOAC) are being increasingly utilised for stroke
prevention in atrial fibrillation (AF) and atrial flutter. Aims To analyse the adoption and …

Background and Purpose—Ischemic stroke (IS) secondary to atrial fibrillation (AF) is largely
preventable with the use of anticoagulation. We sought to identify race-ethnicity and sex …

Background Antithrombotic prophylaxis with oral anticoagulation (OAC) substantially
reduces stroke and mortality in patients with atrial fibrillation (AF). Hypothesis Analysis of …

BACKGROUND: Atrial fibrillation and flutter (AF, collectively) cause stroke. We evaluated
whether treating specialty influences warfarin prescription in patients with newly diagnosed …